House investigation says FDA approval process of Alzheimer’s drug was ‘rife with irregularities’

A congressional investigation found that the US Food and Drug Administration’s “atypical collaboration” to approve a high-priced Alzheimer’s drug was “rife with irregularities.” 

Article Source: Latest From CNN Read More